NVIDIA's BindClaw uses agents for protein design: 15 of 18 binders hit calmodulin

sokrypton · x · 2026-10-29

NVIDIA's Digital Biology team unveiled BindClaw, an agentic protein design system that starts from a prompt or paper, defines the biological mechanism, builds mechanism-specific computational assays, and iteratively designs binders. Agents evaluate designs against biological objectives like competing with native partners and preferring molecular states. In a human-guided calmodulin campaign, 15 of 18 designs bound calcium-loaded CaM—including subnanomolar binders validated by both BLI and SPR—while 13 of 15 showed no binding to calcium-depleted CaM. Code will be released in a few weeks.

Original post →

More from coding & agent

coding & agent channel →